OTC Pharmaceuticals in India

Datamonitor's OTC Pharmaceuticals in India industry profile is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry. It includes data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.

Scope

* Contains an executive summary and data on value, volume and/or segmentation

* Provides textual analysis of OTC Pharmaceuticals in India’s recent performance and future prospects

* Incorporates in-depth five forces competitive environment analysis and scorecards

* Includes a five-year forecast of OTC Pharmaceuticals in India

* The leading companies are profiled with supporting key financial metrics

* Supported by the key macroeconomic and demographic data affecting the market

Highlights

* Detailed information is included on market size, measured by both value and volume

* Five forces scorecards provide an accessible yet in depth view of the market’s competitive landscape

* Market shares are covered by manufacturer and/or brand

* Also features market breakdown by distribution channel

Why you should buy this report

* Spot future trends and developments

* Inform your business decisions

* Add weight to presentations and marketing materials

* Save time carrying out entry-level research

Market Definition

The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirinand other analgesics), and medicated skin products (anti-bacteria’s, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters & bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness).

For the purposes of this report, Asia-Pacific comprises Australia, China, India, Japan, Singapore, South Korea, and Taiwan.

[Fade out the market survey infos]

TABLE OF CONTENTS
EXECUTIVE SUMMARY 2
MARKET OVERVIEW 7
Market definition 7
Research highlights 8
Market analysis 9
MARKET VALUE 10
MARKET SEGMENTATION I 11
MARKET SEGMENTATION II 12
MARKET SHARE 13
FIVE FORCES ANALYSIS 14
Summary 14
Buyer power 16
Supplier power 17
New entrants 18
Substitutes 20
Rivalry 21
LEADING COMPANIES 22
Cipla Ltd 22
Johnson & Johnson 27
GlaxoSmithKline Plc 32
MARKET DISTRIBUTION 37
MARKET FORECASTS 38
Market value forecast 38
MACROECONOMIC INDICATORS 39
APPENDIX 41
Methodology 41
Industry associations 42
Related Datamonitor research 42
Disclaimer 44
ABOUT DATAMONITOR 45
Premium Reports 45
Summary Reports 45
Datamonitor consulting 45

LIST OF TABLES
Table 1: India OTC pharmaceuticals market value: $ million, 2005–09 10
Table 2: India OTC pharmaceuticals market segmentation I:% share, by value, 2009 11
Table 3: India OTC pharmaceuticals market segmentation II: % share, by value, 2009 12
Table 4: India OTC pharmaceuticals market share: % share, by value, 2009 13
Table 5: Cipla Ltd: key facts 22
Table 6: Cipla Ltd: key financials ($) 24
Table 7: Cipla Ltd: key financials (Rs.) 24
Table 8: Cipla Ltd: key financial ratios 25
Table 9: Johnson & Johnson: key facts 27
Table 10: Johnson & Johnson: key financials ($) 29
Table 11: Johnson & Johnson: key financial ratios 30
Table 12: GlaxoSmithKline Plc: key facts 32
Table 13: GlaxoSmithKline Plc: key financials ($) 34
Table 14: GlaxoSmithKline Plc: key financials (£) 35
Table 15: GlaxoSmithKline Plc: key financial ratios 35
Table 16: India OTC pharmaceuticals market distribution: % share, by value, 2009 37
Table 17: India OTC pharmaceuticals market value forecast: $ million, 2009–14 38
Table 18: India size of population (million), 2005–09 39
Table 19: India gdp (constant 2000 prices, $ billion), 2005–09 39
Table 20: India gdp (current prices, $ billion), 2005–09 39
Table 21: India inflation, 2005–09 40
Table 22: India consumer price index (absolute), 2005–09 40
Table 23: India exchange rate, 2005–09 40

LIST OF FIGURES
Figure 1: India OTC pharmaceuticals market value: $ million, 2005–09 10
Figure 2: India OTC pharmaceuticals market segmentation I:% share, by value, 2009 11
Figure 3: India OTC pharmaceuticals market segmentation II: % share, by value, 2009 12
Figure 4: India OTC pharmaceuticals market share: % share, by value, 2009 13
Figure 5: Forces driving competition in the OTC pharmaceuticals market in India, 2009 14
Figure 6: Drivers of buyer power in the OTC pharmaceuticals market in India, 2009 16
Figure 7: Drivers of supplier power in the OTC pharmaceuticals market in India, 2009 17
Figure 8: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in India, 2009 18
Figure 9: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in India, 2009 20
Figure 10: Drivers of degree of rivalry in the OTC pharmaceuticals market in India, 2009 21
Figure 11: Cipla Ltd: revenues & profitability 25
Figure 12: Cipla Ltd: assets & liabilities 26
Figure 13: Johnson & Johnson: revenues & profitability 30
Figure 14: Johnson & Johnson: assets & liabilities 31
Figure 15: GlaxoSmithKline Plc: revenues & profitability 36
Figure 16: GlaxoSmithKline Plc: assets & liabilities 36
Figure 17: India OTC pharmaceuticals market distribution: % share, by value, 2009 37
Figure 18: India OTC pharmaceuticals market value forecast: $ million, 2009–14 38


[Fade out table of contents]